OXYCONTIN OPOID CRISIS IN USA PURDUE PHARMA LC

Purdue Pharma USA based company has stated that it will increase its pay up to $6 billion because of the company's involvement in the opioid epidemic crisis in the USA

Purdue Pharma, the manufacturer of OxyContin, have decided to remove their criticism to an agreement granting them immunity from opioid litigation with nine state attorneys.

Earlier Purdue pharma said to pay 4-5 billion, Robert Ferguson, the state's attorney general, called the conditions of the latest deal a success.

California, Connecticut, Delaware, Maryland, New Hampshire, Oregon, and Vermont, is demanding more money.

However, Washington is among the states with the highest overdose fatality rates in the nation and is requesting extra money from the Sacklers.

Sackler's family is denying any wrongdoing, and said the company has no large resources to reach the community's need.

However, deal not yet final by U.S. Bankruptcy Judge Robert Drain who is handling the case.

Advocacy groups for drug users are incensed that time and resources were diverted from overdose and addiction prevention to this case.

Share This if You Like